Back
Insperity, Inc. Vs. MiNK Therapeutics, Inc. Industry Stock Comparison
Sell
31
NSP
Insperity, Inc.
Last Price:
$38.63
Seasonality Move:
3.23%
Sell
27
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
Sell
31
Insperity, Inc. (NSP)
is a Sell
Is Insperity, Inc. a Buy, Sell or Hold?
-
The current Insperity, Inc. [NSP] share price is $39.44. The Score for NSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
NSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?
-
The current MiNK Therapeutics, Inc. [INKT] share price is $11.53. The Score for INKT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NSP Stock Price Chart
What is Insperity, Inc.'s stock price today?
-
The Insperity, Inc. share price today is $39.44The current trend is relatively stagnant and NSP is experiencing slight selling pressure.
INKT Stock Price Chart
What is MiNK Therapeutics, Inc.'s stock price today?
-
The MiNK Therapeutics, Inc. share price today is $11.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.
NSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 60.37 | Buy |
| Chaikin Money Flow: | -312644 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.07 - 37.69) | Buy |
| Bollinger Bands (100): | (37.73 - 53.47) | Sell |
INKT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 44.15 | Sell |
| Chaikin Money Flow: | -6795 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.89 - 12.47) | Sell |
| Bollinger Bands (100): | (12.26 - 15.22) | Sell |
NSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.9 | Buy |
| 20-day SMA: | 36.15 | Buy |
| 50-day SMA: | 39.1 | Buy |
| 200-day SMA: | 58.43 | Sell |
| 8-day EMA: | 38.16 | Buy |
| 20-day EMA: | 37.11 | Buy |
| 50-day EMA: | 39.53 | Sell |
| 200-day EMA: | 55.2 | Sell |
INKT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.26 | Sell |
| 20-day SMA: | 11.59 | Sell |
| 50-day SMA: | 12.86 | Sell |
| 200-day SMA: | 11.87 | Sell |
| 8-day EMA: | 11.94 | Sell |
| 20-day EMA: | 12 | Sell |
| 50-day EMA: | 12.64 | Sell |
| 200-day EMA: | 12.22 | Sell |
Insperity, Inc. Earnings Growth & NSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.38 per share, and an increase next year of $1.58 per share.
MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
Insperity, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MiNK Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||